Governance Takara Bio Inc.

4974

JP3460200003

Biotechnology & Medical Research

Market Closed - Japan Exchange Other stock markets 01:30:00 2026-02-13 am EST			5-day change	1st Jan Change
801.00 ^JPY	-2.20%		+0.50%	+0.75%

Feb. 13	Takara Holdings Inc. proposed to acquire remaining 39.09% stake in Takara Bio Inc. from group of shareholders for ¥54.1 billion.	CI
Feb. 13	Takara Bio Inc. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2026	CI

Executive Committee: Takara Bio Inc.

Manager

Positions heldSince

Tsuyoshi Miyamura

62 year

Chief Executive Officer	-
President	2025-06-23

Kazuki Yamamoto

Sales & Marketing

2015-06-25

Masahide Tamaki

66 year

Comptroller/Controller/Auditor

2019-05-31

Junichi Mineno

65 year

Chief Operating Officer

2020-03-31

Shuichiro Matsuzaki

70 year

Director of Finance/CFO

2019-12-31

Akihiko Kita

66 year

Comptroller/Controller/Auditor

2016-05-31

Takuya Kakemi

Chief Administrative Officer	-
Investor Relations Contact	-

Noritaka Nishiwaki

Human Resources Officer

Composition of the Board of Directors: Takara Bio Inc.

Director

CommitteesSince

Koichi Nakao

63 year

Chairman

2025-06-23

Nobuko Kawashima

63 year

Compensation Committee	2021-05-31
Nominating Committee	2021-05-31

Noriomi Matsumura

54 year

Director/Board Member	2020-05-31
Independent Dir/Board Member	2020-05-31

Kazuko Kimura

74 year

Director/Board Member	2019-05-31
Independent Dir/Board Member	2019-05-31

Masanobu Kimura

62 year

Director/Board Member

2017-05-31

Shuichiro Matsuzaki

70 year

Director/Board Member

2014-05-31

Junichi Mineno

65 year

Director/Board Member

2014-05-31

Tsuyoshi Miyamura

62 year

Director/Board Member

2018-05-31

Former Officers and Directors: Takara Bio Inc.

Insider

Positions held

SinceUntil

Hisashi Omiya

Chairman

2002-03-31

2025-06-23

Mutsumi Kimura

Director/Board Member	2010-01-20	2014-06-23
Director of Finance/CFO	2012-11-22	2014-06-23
Investor Relations Contact	2012-11-22	2014-06-23
Corporate Officer/Principal	2010-01-20	2012-11-22

Makoto Moriguchi

Director/Board Member	2012-09-25	2014-06-23
Corporate Officer/Principal	2010-01-20	2014-06-23

Takao Okane

Chief Administrative Officer	2017-06-22	-
Director/Board Member	2014-05-31	-
Human Resources Officer	2017-03-31	-
Corporate Officer/Principal	2014-05-31	2017-05-31

Shinji Ueda

Director/Board Member

2013-05-31

Jawaharlal Bhatt

Director/Board Member	2010-05-31	-
Independent Dir/Board Member	2010-05-31	-

Tsutomu Nomura

Comptroller/Controller/Auditor

2010-11-30

Hajime Nishikawa

Comptroller/Controller/Auditor

2010-11-30

Kiyozo Asada

Comptroller/Controller/Auditor	2011-05-31	-
Director/Board Member	2010-01-20	2011-05-31
Corporate Officer/Principal	2010-01-20	2011-05-31

Kazutoh Takesako

Director/Board Member	2009-05-31	-
Corporate Officer/Principal	2010-01-20	-

Susumu Sano

Comptroller/Controller/Auditor

2010-01-20

Ei Yamada

Director/Board Member

2001-07-31

Hiroyuki Mukai

Director/Board Member	2010-01-20	2010-01-20
Corporate Officer/Principal	2010-01-20	-

Masanobu Kimura

Director/Board Member

Hiroaki Miyazawa

Corporate Officer/Principal

2010-11-30

Masaharu Watabe

Director of Finance/CFO	2014-05-31	-
Investor Relations Contact	2014-05-31	-
Public Communications Contact	-	-

Age distribution of managers

Parity Men Women

Male	13
Female	2

Of which Executive Committee

Male	8
Female	0

Of which Directors

Male	6
Female	2

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

TAKARA BIO INC. is a Japan-based company principally engaged in bio-industry support business and gene medicine business. The Company operates in three business segments. Bioindustry Support segment provides reagents for research (genetic engineering reagents, cell engineering reagents, protein engineering reagents), scientific instruments, contract services and license fees for gene related patents to research institutes, such as universities and companies where biotechnology research and development are conducted. Gene Medicine segment provides gene therapy-related development and sale licensing fees and trial products as an application field of genetic engineering technology and cell engineering technology which is core technology cultivated in development of research reagents. Medical Food and Biotechnology segment provides health food and health food research and development services, license fees for health food related patents, as well as license fees for mushrooms.

Employees

1,779

Sector

Biotechnology & Medical Research

Calendar

May. 06 - Q4 2026 Earnings Release (Projected)

More about the company